| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/17/2008 | WO2007048645A3 Protection of oxidizable agents |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015240 Acid Salt of Benzimidazole Derivative and Crystal Thereof |
| 01/17/2008 | US20080015234 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015222 New Heterocyclic Amides |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015204 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015182 Potent PARP Inhibitors |
| 01/17/2008 | US20080015177 S1P receptor modulating compounds and use thereof |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015155 Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye |
| 01/17/2008 | US20080015153 Pharmaceutical compositions containing the long pentraxin PTX3 |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080015149 Galectin 11 |
| 01/17/2008 | US20080014281 Chitin Micro-Particles As An Adjuvant |
| 01/17/2008 | US20080014253 Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014223 Syrup Composition Comprising Dexibupropen as an Active Ingredient and Method for the Preparation Thereof |
| 01/17/2008 | US20080014201 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
| 01/17/2008 | US20080014184 Treating fibromyalgia in a subject who has small intestinal bacterial overgrowth (SIBO) by administering a composition comprising a therapeutic agent selected from an antimicrobial agent, an antibiotic, and combinations thereof |
| 01/17/2008 | DE102006031224A1 New sulfoximine-substituted pyrimidines useful for treating e.g. diseases caused by inflammatory, allergic or proliferative processes, oncological diseases, cancer, eye, autoimmune and neurodegerative diseases |
| 01/17/2008 | CA2658417A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| 01/17/2008 | CA2657332A1 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 01/17/2008 | CA2657300A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 01/17/2008 | CA2657227A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | CA2657133A1 Anti-human .alpha.9 integrin antibody and use of the same |
| 01/17/2008 | CA2655750A1 2-arylindole derivatives as mpges-1 inhibitors |
| 01/17/2008 | CA2551163A1 Methods for treating inflammatory, autoimmune or bone resorption diseases |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878733A1 Pyrimidine derivatives as ALK-5 inhibitors |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878446A2 Formulation comprising buprenorphine |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1877427A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 01/16/2008 | EP1877410A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity |
| 01/16/2008 | EP1877400A1 Vanilloid receptor ligands and their use in treatments |
| 01/16/2008 | EP1877385A1 Pyrimidines and pyrazines useful as modulators of ion channels |
| 01/16/2008 | EP1877381A1 Pyridines useful as modulators of ion channels |
| 01/16/2008 | EP1877366A1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity |
| 01/16/2008 | EP1877057A1 Use of pyrazolyl-pyrimidine derivatives in the treatment of pain |
| 01/16/2008 | EP1877046A2 Use of radical capturing substances in a topical preparation for antipyretic treatment |
| 01/16/2008 | EP1786823B1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 01/16/2008 | EP1567486B1 Bis-aryl sulfonamides |
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1315793B1 Methods for culturing human lung mast cells and uses thereof |
| 01/16/2008 | EP1279039B1 Diagnostic assay involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/16/2008 | EP1278532B1 Plant extract of the olea europaea species as no-synthase inhibitor and uses |
| 01/16/2008 | EP1223981B1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | CN101107239A N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid CB1 receptor antagonists |
| 01/16/2008 | CN101107233A 1H-imidiazole derivatives as cannabinoid CB2 receptor modulators |
| 01/16/2008 | CN101104602A N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfamide derivative and its preparation and use |
| 01/16/2008 | CN101104058A Medicine for treating multi-inflammatory toothache and its preparation thereof |
| 01/16/2008 | CN101104055A Internal-applied traditional Chinese medicine for treating common cold |
| 01/16/2008 | CN101104036A Traditional Chinese medicinal liquid for treating rheumatic arthritis and rheumatoid arthritis |
| 01/16/2008 | CN101104028A Traditional Chinese medicine formula for treating heat stroke cold |
| 01/16/2008 | CN101104016A Oral solid preparation of corydalis and its new use |
| 01/16/2008 | CN101104015A Olive soft capsule raw material formulation and its preparation technology |
| 01/16/2008 | CN101104009A Angelica polymorpha extract and its medicinal use |
| 01/16/2008 | CN101104004A Medicine for treating hyperosteogeny and rheumatic arthritis and its preparing method |
| 01/16/2008 | CN101103872A Cervical vertebra recovering pillow |
| 01/16/2008 | CN101103755A Method for producing convenient nutritive rice-tea and product |
| 01/16/2008 | CN100361652C Gel type dexketoprofen plaster and method for preparing the same |
| 01/16/2008 | CN100361651C Intravenous nanoparticles for targenting drug delivery and sustained drug release |
| 01/15/2008 | US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2132740C Pharmaceutical composition containing cyclosporin derivative |
| 01/15/2008 | CA2123405C Angiostatic steroids |
| 01/10/2008 | WO2008005570A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/10/2008 | WO2008005451A2 Optical apparatus and methods for chemical analysis |
| 01/10/2008 | WO2008005348A1 Synthesis of diethyl{ i5' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | WO2008005303A2 Thiazolopyrimidine modulators of trpv1 |
| 01/10/2008 | WO2008005084A2 Methods to prevent and treat diseases |
| 01/10/2008 | WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 01/10/2008 | WO2008004406A1 Agent for modulating mast cell degranulation |
| 01/10/2008 | WO2008003978A2 Dioxo-alkanes and dioxo-alkenes |
| 01/10/2008 | WO2008003855A2 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 01/10/2008 | WO2008003770A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 01/10/2008 | WO2008003697A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use |
| 01/10/2008 | WO2008003484A2 Agent containing chrysin and cholic acid for reducing weight, accelerating lipid catabolism, and/or restricting calories |
| 01/10/2008 | WO2008003314A1 A method of preparing a glycoside of a mono- or diacylglycerol product from a plant material |
| 01/10/2008 | WO2008003141A1 Therapeutic compounds |
| 01/10/2008 | WO2007131764A3 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 01/10/2008 | WO2007121921A3 Purine derivatives for use as adenosin a2a receptor agonists |